Ablation for malignant liver tumor using high-intensity focused ultrasound and radio-frequency: A meta-analysis

CONCLUSION: The meta-analysis shows no significant difference in efficacy, long-term survival rates, or complication rates between HIFU and RF ablation for primary liver cancer, but more large-scale, high-quality randomized clinical trials are needed to prove their equivalence. Both therapy strategies seem promising, but additional information is needed to determine their respective merits.PMID:38517812 | DOI:10.3233/THC-230868
Source: Technology and Health Care - Category: Medical Devices Authors: Source Type: research